Stock Events

Regeneron Pharmaceuticals (REGN) Q1 2022 Earnings

4FebConfirmed
Q2 2021
Q3 2021
Q4 2021
Q1 2022
8.47
14.25
20.02
25.8

Details

Expected EPS
18.59
Actual EPS
21.32
Surprise EPS
2.73
Surprise Percent
+14.69%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 21.32 per share for Q1 2022.

0 Comments

Share your thoughts